Sanofi’s net profit slipped 2.4 percent in the third quarter as the maker of the Lantus diabetes treatment booked a higher charge for restructuring at its French operations. The drugmaker said Tuesday that its net profit was 1.9 billion euros in the third quarter, down from 1.22 billion euros a year earlier.

Click here to read original article